Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetically Informed Prostate Cancer Treatment for Metastatic Disease.

The Urologic clinics of North America - 1 Aug 2021

Siebert Aisha L, Szymaniak Brittany M, Numan Yazan, Morgans Alicia K

Abstract excerpt

Germline testing should be performed to support treatment selection for patients with metastatic prostate cancer, and should be identified in patients with high-risk localized disease. Patients with germline BRCA1/2 mutations should be educated regarding additional personal cancer risk, and risk for family members. Guidelines recommend that all men with metastatic prostate cancer should also undergo somatic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, BRCA2
Share to Antibodies, Monoclonal, Humanized
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Indoles

Share to Neoplasm Metastasis

Share to Phthalazines

Share to Piperazines

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 34210491
DOI: 10.1016/j.ucl.2021.03.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetically Informed Prostate Cancer Treatment for Metastatic Disease.PMID 34210491Read ↗

BRCA Germline Mutations in Prostate Cancer: The Future Is TailoredSemantic proximity Read ↗

Germline genetics of prostate cancer.Semantic proximity Read ↗

Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testingSemantic proximity Read ↗

Germline and somatic mutations in prostate cancer: Implications for treatment.Semantic proximity Read ↗

Genetic testing in prostate cancer management: Considerations informing primary care.Semantic proximity Read ↗

Prostate cancer and genetic contributions.Semantic proximity Read ↗

Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate CancerSemantic proximity Read ↗

Genetic and Genomic Testing for Prostate Cancer: Beyond DNA RepairSemantic proximity Read ↗

Recent Insights on Genetic Testing in Primary Prostate Cancer.Semantic proximity Read ↗

Genetically Informed Prostate Cancer Screening.Semantic proximity Read ↗

Germline mutations and prostate cancer: is it time to change treatment algorithms?Semantic proximity Read ↗

Genetic testing for hereditary prostate cancer: Current status and limitations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.